logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

BRCA+ ovarian cancer: heavily treated patients retain chemosensitivity in Spanish study

Primary PFI, platinum-based CT, and PARP-inhibitors strongly predict outcomes.